Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
176,822,166
-
Share change
-
+803,788
-
Total reported value
-
$27,082,266,094
-
Put/Call ratio
-
91%
-
Price per share
-
$153.17
-
Number of holders
-
866
-
Value change
-
+$78,816,316
-
Number of buys
-
316
-
Number of sells
-
421
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2018
As of 31 Dec 2018 Edwards Lifesciences Corp - Common Stock (EW) had 866 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 176,822,166 shares of stock of the company.
Largest 10 holders included Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Bank of New York Mellon Corp, ALLIANCEBERNSTEIN L.P., JENNISON ASSOCIATES LLC, and Capital Research Global Investors.
This table shows 866 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.